# FDA recall D-0008-2026

> **Dr. Reddy's Laboratories, Inc.** · Class II · drug recall initiated 2025-09-26.

## Product

Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540.  NDC: 43598-666-25

## Reason for recall

Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

## Distribution

Nationwide within the USA.

## Key facts

- **Recall number:** D-0008-2026
- **Recalling firm:** Dr. Reddy's Laboratories, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-09-26
- **Report date:** 2025-10-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0008-2026

## Citation

> AI Analytics. FDA recall D-0008-2026. Retrieved 2026-08-23 from https://api.ai-analytics.org/recall/D-0008-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*